Delivery Order SPE2DE21D7010-SPE2D626F07PW
Award Date 1/14/26
Potential Completion Date 2/4/26
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $2,860.94 for OSTEOCEL PRO on October 28, 2025, with an ultimate completion date of November 18, 2025. This fixed-price delivery order with economic price adjustment mechanism was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a defense agency that procures medical supplies and equipment for Department of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $23,948.58 fixed-price delivery order for OSTEOCEL PRO bone graft material on December 18, 2025, with completion targeted for January 9, 2026. The contract carries no set-aside designation and is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order for allograft products valued at $1,367.40 by the Defense Logistics Agency Medical Supply Chain on December 30, 2025, with an ultimate completion date of January 21, 2026. This fixed-price contract with economic price adjustment mechanisms was issued without set-aside restrictions, reflecting Nuvasive's competitive standing in...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,839.63 for allograft products on November 25, 2025, with an ultimate completion date of December 23, 2025. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $1,823.20 delivery order (Contract No. 4570097953) by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, for allograft products. The contract represents a firm fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of December 3, 2025. This award was made without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $1,685.40 fixed-price delivery order with economic price adjustment on December 11, 2025, for allograft products to support federal healthcare operations. This delivery order, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and scheduled for completion by January 2, 2026, with performance...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $3,650.98 fixed-price delivery order with economic price adjustment (Contract No. 4570280058, "ARCHON DEGENERATIVE") by the Defense Logistics Agency Medical Supply Chain on November 26, 2025. The delivery order, with a completion date of January 5, 2026, represents a competitive open-market procurement without set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $3,220.96 for COROENT SMALL INTERLOCK spinal implant products on October 30, 2025. This fixed-price delivery order with economic price adjustment provisions is funded through the Defense Logistics Agency Medical Supply Chain, a defense-focused entity responsible for procuring medical supplies and equipment for...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...